i-SENS, Inc.

KOSDAQ 099190.KQ

i-SENS, Inc. Return on Assets (ROA) for the year ending December 31, 2023: 0.74%

i-SENS, Inc. Return on Assets (ROA) is 0.74% for the year ending December 31, 2023, a -79.29% change year over year. Return on assets measures profitability against assets; higher ROA indicates efficient asset use and profitability.

i-SENS, Inc. Return on Assets (ROA) for the year ending December 31, 2022 was 3.59%, a -39.47% change year over year.
i-SENS, Inc. Return on Assets (ROA) for the year ending December 31, 2021 was 5.93%, a -32.16% change year over year.
i-SENS, Inc. Return on Assets (ROA) for the year ending December 31, 2020 was 8.74%, a 0.77% change year over year.
i-SENS, Inc. Return on Assets (ROA) for the year ending December 31, 2019 was 8.67%, a -3.34% change year over year.

Key data

Date	Return on Assets (ROA)	Return on Equity (ROE)	Return on Capital Employed (ROCE)	Interest Coverage Ratio

KOSDAQ: 099190.KQ

i-SENS, Inc.

CEO	Dr. Geun-Sig Cha
IPO Date	Jan. 30, 2013
Location	South Korea
Headquarters	43, Banpo-daero 28-gil
Employees	687
Sector	Health Care
Industries Medical Instruments Biotechnology Pharmaceuticals

Description

i-SENS, Inc. provides diagnostic biosensors in South Korea. The company offers point of care testing devices, such as HbA1c, blood gas, electrolyte, and PT/INR analyzers; CareSens blood glucose monitoring systems; and lancing and other ancillary devices, as well as diabetes management services. It exports its products to approximately 110 countries, including the United States, Japan, and Europe. The company was founded in 2000 and is headquartered in Seoul, South Korea.

Key trends

Past 5 years